Latest schizophrenia Stories
DUBLIN, March 28, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/cw7xqm/investigation) has announced the addition of the
NEW YORK, March 27, 2014 /PRNewswire/ -- Elsevier [http://www.elsevier.com ], a world-leading provider of scientific, technical and medical information products and services,
The Firm is investigating Risperdal lawsuits on behalf of men and boys who developed gynecomastia (male breast growth), allegedly due to their use of Risperdal. New
Independent Data Monitoring Committee Recommends Halting Trial and Unblinding Data Based on Treatment Efficacy TITUSVILLE, N.J., March 20, 2014 /PRNewswire/ -- Janssen Research & Development,
Flood Law Group today announced that they are now actively investigating claims on behalf of men and boys who have been diagnosed with gynecomastia after taking the prescription drug Risperdal.
MOUNTAIN VIEW, Calif. and BARCELONA, Spain, March 13, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc.
A pharmaceutical product liability litigation firm, Carey Danis & Lowe, is currently investigating an alleged Risperdal side effect, male breast growth.
NEW YORK, March 10, 2014 /PRNewswire/ -- Intra-Cellular Therapies, Inc.
-- Significantly Higher Drug Exposure Achieved with Continued Tolerability -- SEATTLE, March 6, 2014 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced additional positive
The global market for drugs used to treat mental disorders was valued at $70.1 billion in 2012 and is estimated to have declined slightly to nearly $69 billion in 2013.